» Articles » PMID: 20489162

Low Doses of Lipopolysaccharide and Minimally Oxidized Low-density Lipoprotein Cooperatively Activate Macrophages Via Nuclear Factor Kappa B and Activator Protein-1: Possible Mechanism for Acceleration of Atherosclerosis by Subclinical Endotoxemia

Overview
Journal Circ Res
Date 2010 May 22
PMID 20489162
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Oxidized low-density lipoprotein (LDL) is an important determinant of inflammation in atherosclerotic lesions. It has also been documented that certain chronic infectious diseases, such as periodontitis and chlamydial infection, exacerbate clinical manifestations of atherosclerosis. In addition, low-level but persistent metabolic endotoxemia is often found in diabetic and obese subjects and is induced in mice fed a high-fat diet.

Objective: In this study, we examined cooperative macrophage activation by low levels of bacterial lipopolysaccharide (LPS) and by minimally oxidized LDL (mmLDL), as a model for subclinical endotoxemia-complicated atherosclerosis.

Methods And Results: We found that both in vitro and in vivo, mmLDL and LPS (Kdo2-LipidA) cooperatively activated macrophages to express proinflammatory cytokines Cxcl2 (MIP-2), Ccl3 (MIP-1alpha), and Ccl4 (MIP-1beta). Importantly, the mmLDL and LPS cooperative effects were evident at a threshold LPS concentration (1 ng/mL) at which LPS alone induced only a limited macrophage response. Analyzing microarray data with a de novo motif discovery algorithm, we found that genes transcribed by promoters containing an activator protein (AP)-1 binding site were significantly upregulated by costimulation with mmLDL and LPS. In a nuclear factor-DNA binding assay, the cooperative effect of mmLDL and LPS costimulation on c-Jun and c-Fos DNA binding, but not on p65 or p50, was dependent on mmLDL-induced activation of extracellular signal-regulated kinase (ERK) 1/2. In addition, mmLDL induced c-Jun N-terminal kinase (JNK)-dependent derepression of AP-1 by removing nuclear receptor corepressor (NCoR) from the chemokine promoters.

Conclusions: The cooperative engagement of AP-1 and nuclear factor (NF)-kappaB by mmLDL and LPS may constitute a mechanism of increased transcription of inflammatory cytokines within atherosclerotic lesions.

Citing Articles

Bacterial lipopolysaccharide model of neuroinflammation-associated neurodegeneration in Wistar rats: A comparison between different durations of lipopolysaccharide induction.

Blossom V, Ullal S, Rai R, Chakraborthi S, Kumar N, Pai M Vet World. 2025; 17(11):2567-2576.

PMID: 39829657 PMC: 11736368. DOI: 10.14202/vetworld.2024.2567-2576.


Deciphering the Role of Copper Homeostasis in Atherosclerosis: From Molecular Mechanisms to Therapeutic Targets.

Lv X, Zhao L, Song Y, Chen W, Tuo Q Int J Mol Sci. 2024; 25(21).

PMID: 39519014 PMC: 11546650. DOI: 10.3390/ijms252111462.


Bixin, a New Atheroprotective Carotenoid Candidate, Prevents oxLDL-Induced Cytotoxicity and Mitochondrial Dysfunction in Macrophages: Involvement of the Nrf2 and NF-κB Pathways.

Somacal S, Schuler da Silva L, de Oliveira J, Emanuelli T, de Bem A Foods. 2024; 13(13).

PMID: 38998509 PMC: 11241531. DOI: 10.3390/foods13132002.


Resolving neutrophils through genetic deletion of TRAM attenuate atherosclerosis pathogenesis.

Geng S, Zhang Y, Lu R, Irimia D, Li L iScience. 2024; 27(6):110097.

PMID: 38883832 PMC: 11179630. DOI: 10.1016/j.isci.2024.110097.


Immune Homeostasis Maintenance Through Advanced Immune Therapeutics to Target Atherosclerosis.

Geng S, Wu Y, Li L Methods Mol Biol. 2024; 2782:25-37.

PMID: 38622390 DOI: 10.1007/978-1-0716-3754-8_2.


References
1.
Sasik R, Woelk C, Corbeil J . Microarray truths and consequences. J Mol Endocrinol. 2004; 33(1):1-9. DOI: 10.1677/jme.0.0330001. View

2.
Brandtzaeg P, Bjerre A, Ovstebo R, Brusletto B, Joo G, Kierulf P . Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res. 2001; 7(6):401-20. View

3.
Kallio K, Buhlin K, Jauhiainen M, Keva R, Tuomainen A, Klinge B . Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun. 2008; 14(4):247-53. DOI: 10.1177/1753425908095130. View

4.
Chalmers C, Gilley R, March H, Balmanno K, Cook S . The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal. 2006; 19(4):695-704. DOI: 10.1016/j.cellsig.2006.09.001. View

5.
Wurfel M, Kunitake S, Lichenstein H, Kane J, Wright S . Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med. 1994; 180(3):1025-35. PMC: 2191628. DOI: 10.1084/jem.180.3.1025. View